204 related articles for article (PubMed ID: 29197803)
21. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.
Hasanein P; Shahidi S; Komaki A; Mirazi N
Eur J Pharmacol; 2008 Sep; 591(1-3):132-5. PubMed ID: 18593578
[TBL] [Abstract][Full Text] [Related]
22. Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats.
Toczek M; Schlicker E; Grzęda E; Malinowska B
Life Sci; 2015 Oct; 138():78-85. PubMed ID: 25921770
[TBL] [Abstract][Full Text] [Related]
23. Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain.
Jhaveri MD; Richardson D; Kendall DA; Barrett DA; Chapman V
J Neurosci; 2006 Dec; 26(51):13318-27. PubMed ID: 17182782
[TBL] [Abstract][Full Text] [Related]
24. Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease.
Celorrio M; Fernández-Suárez D; Rojo-Bustamante E; Echeverry-Alzate V; Ramírez MJ; Hillard CJ; López-Moreno JA; Maldonado R; Oyarzábal J; Franco R; Aymerich MS
Brain Behav Immun; 2016 Oct; 57():94-105. PubMed ID: 27318096
[TBL] [Abstract][Full Text] [Related]
25. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181
[TBL] [Abstract][Full Text] [Related]
26. Effect of Fatty Acid Amide Hydrolase Inhibitor URB597 on Orofacial Pain Perception in Rats.
Zubrzycki M; Zubrzycka M; Wysiadecki G; Szemraj J; Jerczynska H; Stasiolek M
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563056
[TBL] [Abstract][Full Text] [Related]
27. URB597 Prevents the Short-Term Excitotoxic Cell Damage in Rat Cortical Slices: Role of Cannabinoid 1 Receptors.
Chavira-Ramos K; Orozco-Morales M; Karasu Ç; Tinkov AA; Aschner M; Santamaría A; Colín-González AL
Neurotox Res; 2021 Apr; 39(2):146-155. PubMed ID: 33141426
[TBL] [Abstract][Full Text] [Related]
28. Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.
Bátkai S; Pacher P; Osei-Hyiaman D; Radaeva S; Liu J; Harvey-White J; Offertáler L; Mackie K; Rudd MA; Bukoski RD; Kunos G
Circulation; 2004 Oct; 110(14):1996-2002. PubMed ID: 15451779
[TBL] [Abstract][Full Text] [Related]
29. Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus.
Schlosburg JE; Boger DL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2009 Apr; 329(1):314-23. PubMed ID: 19168707
[TBL] [Abstract][Full Text] [Related]
30. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
Danandeh A; Vozella V; Lim J; Oveisi F; Ramirez GL; Mears D; Wynn G; Piomelli D
Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159
[TBL] [Abstract][Full Text] [Related]
31. The Endocannabinoid System Affects Myocardial Glucose Metabolism in the DOCA-Salt Model of Hypertension.
Polak A; Harasim-Symbor E; Malinowska B; Kasacka I; Lewandowska A; Chabowski A
Cell Physiol Biochem; 2018; 46(2):727-739. PubMed ID: 29621749
[TBL] [Abstract][Full Text] [Related]
32. Effects of hypertension and FAAH inhibitor treatment of rats with primary and secondary hypertension considering the physicochemical properties of erythrocytes.
Dobrzyńska I; Szachowicz-Petelska B; Pędzińska-Betiuk A; Figaszewski ZA; Skrzydlewska E
Toxicol Mech Methods; 2020 May; 30(4):297-305. PubMed ID: 32028814
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
Nozaki C; Markert A; Zimmer A
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421
[TBL] [Abstract][Full Text] [Related]
34. Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat.
Murillo-Rodríguez E; Vázquez E; Millán-Aldaco D; Palomero-Rivero M; Drucker-Colin R
Eur J Pharmacol; 2007 May; 562(1-2):82-91. PubMed ID: 17336288
[TBL] [Abstract][Full Text] [Related]
35. Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat.
Cross-Mellor SK; Ossenkopp KP; Piomelli D; Parker LA
Psychopharmacology (Berl); 2007 Feb; 190(2):135-43. PubMed ID: 17111174
[TBL] [Abstract][Full Text] [Related]
36. Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats.
Haller J; Barna I; Barsvari B; Gyimesi Pelczer K; Yasar S; Panlilio LV; Goldberg S
Psychopharmacology (Berl); 2009 Jul; 204(4):607-16. PubMed ID: 19259645
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
[TBL] [Abstract][Full Text] [Related]
38. Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors.
Storr MA; Keenan CM; Emmerdinger D; Zhang H; Yüce B; Sibaev A; Massa F; Buckley NE; Lutz B; Göke B; Brand S; Patel KD; Sharkey KA
J Mol Med (Berl); 2008 Aug; 86(8):925-36. PubMed ID: 18493729
[TBL] [Abstract][Full Text] [Related]
39. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
Mattace Raso G; Simeoli R; Russo R; Santoro A; Pirozzi C; d'Emmanuele di Villa Bianca R; Mitidieri E; Paciello O; Pagano TB; Orefice NS; Meli R; Calignano A
Pharmacol Res; 2013 Oct; 76():67-76. PubMed ID: 23917217
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposure.
Rivera P; Fernández-Arjona MDM; Silva-Peña D; Blanco E; Vargas A; López-Ávalos MD; Grondona JM; Serrano A; Pavón FJ; Rodríguez de Fonseca F; Suárez J
Biochem Pharmacol; 2018 Nov; 157():244-257. PubMed ID: 30098312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
